2170 — Suzhou Basecare Medical Income Statement
0.000.00%
Last trade - 00:00
- HK$549.79m
- -HK$166.42m
- CNY207.98m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 55.7 | 81.1 | 107 | 141 | 208 |
Cost of Revenue | |||||
Gross Profit | 26.3 | 27.7 | 51.1 | 59.5 | 91.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 64.4 | 135 | 232 | 267 | 402 |
Operating Profit | -8.73 | -53.5 | -124 | -126 | -194 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -531 | -882 | -126 | -127 | -196 |
Provision for Income Taxes | |||||
Net Income After Taxes | -528 | -874 | -144 | -133 | -193 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -531 | -877 | -144 | -123 | -192 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -531 | -877 | -144 | -123 | -192 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.98 | -3.28 | -0.541 | -0.482 | -0.701 |